Alto Neuroscience, Inc. (ANRO) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Alto Neuroscience, Inc. (US:ANRO), trading at 28.63. In 2021, Alto Neuroscience, Inc. generated $210,000 in revenue and -$9.94 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Alto Neuroscience, Inc. is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 28.63
- Recent Revenue (2021): $210,000
- Free Cash Flow (2021): -$9.94 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.